Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$510M |
| 2 |
Pfizer
PFE
|
+$265M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
Comcast
CMCSA
|
+$191M |
| 5 |
Meta Platforms (Facebook)
META
|
+$184M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$369M |
| 2 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$330M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$230M |
| 4 |
Amgen
AMGN
|
+$223M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.46% |
| 2 | Healthcare | 12.72% |
| 3 | Financials | 10.51% |
| 4 | Industrials | 9.69% |
| 5 | Consumer Staples | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CMD
2126
DELISTED
Cantel Medical Corporation
CMD
| $1.96M | ﹤0.01% |
+31,469
| New | +$1.92M |
|
2127
Brown & Brown
BRO
$23.7B
| $1.95M | ﹤0.01% |
+121,600
| New | +$1.95M |
|
2128
Crown Crafts
CRWS
$31.7M
| $1.95M | ﹤0.01% |
229,900
+17,600
| +8% | +$147K |
|
2129
CNB Financial Corp
CCNE
$1.04B
| $1.95M | ﹤0.01% |
108,040
+41,240
| +62% | +$758K |
|
2130
Commercial Metals
CMC
$7.57B
| $1.95M | ﹤0.01% |
+142,300
| New | +$2.12M |
|
|
EPE
2131
DELISTED
EP Energy Corporation
EPE
| $1.95M | ﹤0.01% |
444,631
-913,969
| -67% | -$4.95M |
|
|
FSYS
2132
DELISTED
FUEL SYSTEMS SOLUTIONS INC COM STK
FSYS
| $1.94M | ﹤0.01% |
397,100
+65,000
| +20% | +$371K |
|
2133
Tandem Diabetes Care
TNDM
$1.3B
| $1.94M | ﹤0.01% |
16,430
+2,547
| +18% | +$253K |
|
|
IVC
2134
DELISTED
Invacare Corporation
IVC
| $1.94M | ﹤0.01% |
111,500
+35,700
| +47% | +$644K |
|
|
NPD
2135
DELISTED
CHINA NEPSTAR CHAIN DRUGSTORE LTD. COM
NPD
| $1.93M | ﹤0.01% |
792,400
+28,600
| +4% | +$67.6K |
|
|
JNP
2136
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
| $1.93M | ﹤0.01% |
187,600
+30,900
| +20% | +$358K |
|
|
HALL
2137
DELISTED
Hallmark Financial Services, Inc.
HALL
| $1.93M | ﹤0.01% |
16,520
+3,710
| +29% | +$459K |
|
2138
Urban One Class D
UONEK
$22.1M
| $1.93M | ﹤0.01% |
112,140
-1,350
| -1% | -$26.6K |
|
|
UWN
2139
DELISTED
Nevada Gold & Casinos, Ltd.
UWN
| $1.93M | ﹤0.01% |
857,500
+37,300
| +5% | +$67.8K |
|
|
SOL
2140
DELISTED
Emeren Group
SOL
| $1.92M | ﹤0.01% |
225,713
+93,473
| +71% | +$656K |
|
|
ENBL
2141
DELISTED
ENABLE MIDSTREAM PARTNERS, LP
ENBL
| $1.92M | ﹤0.01% |
+208,623
| New | +$2.22M |
|
|
SGMO
2142
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $1.91M | ﹤0.01% |
209,400
-276,952
| -57% | -$2.13M |
|
2143
GSI Technology
GSIT
$224M
| $1.91M | ﹤0.01% |
512,800
+43,500
| +9% | +$178K |
|
2144
Peoples Bancorp
PEBO
$1.49B
| $1.91M | ﹤0.01% |
101,200
-20,379
| -17% | -$411K |
|
|
RXDX
2145
DELISTED
Ignyta, Inc.
RXDX
| $1.9M | ﹤0.01% |
142,100
-73,700
| -34% | -$888K |
|
|
CTG
2146
DELISTED
Computer Task Group, Inc.
CTG
| $1.9M | ﹤0.01% |
287,500
+13,800
| +5% | +$93.5K |
|
2147
First Majestic Silver
AG
$7.73B
| $1.9M | ﹤0.01% |
580,500
+448,800
| +341% | +$1.53M |
|
|
VVUS
2148
DELISTED
Vivus Inc
VVUS
| $1.89M | ﹤0.01% |
185,562
+154,839
| +504% | +$2.1M |
|
2149
James River Group Holdings
JRVR
$207M
| $1.89M | ﹤0.01% |
56,400
+38,800
| +220% | +$1.18M |
|
|
ENT
2150
DELISTED
Global Eagle Entertainment Inc.
ENT
| $1.89M | ﹤0.01% |
7,664
+5,464
| +248% | +$1.56M |
|
Similar funds
Renaissance Technologies's Q4 2015 Portfolio in Review
As of Q4 2015, Renaissance Technologies held 3,639 positions worth $45.9B, up 9.5% from $41.9B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Renaissance Technologies deployed $3.07B of net new capital in Q4 2015, opening 509 new positions and adding to 1,872 existing holdings. Its largest new stake was Apple: 17,852,932 shares worth $470M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $369M trimmed.
- Renaissance Technologies's largest Q4 2015 buy was Apple: 17,852,932 shares worth $470M.
- Renaissance Technologies added most to Gilead Sciences in Q4 2015, an estimated $212M increase.
- Renaissance Technologies's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $369M.
- Renaissance Technologies fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $330M.
- Renaissance Technologies's ten largest holdings make up 9.3% of its $45.9B portfolio in Q4 2015.
- Renaissance Technologies opened 509 new positions and closed 386 in Q4 2015.
- Renaissance Technologies's portfolio value rose 9.5% quarter-over-quarter to $45.9B.
Based on Renaissance Technologies's 13F filing for Q4 2015, filed 11 Feb 2016.